About Hindys Lab Private Limited
Data last updated: 21 December 2025
Hindys Lab Private Limited is a private limited company based in Chityal, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 21 September 2007, the company has been in operation for over 19 years.
Registered with ROC Hyderabad under CIN U24100AP2007PTC055636.
Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹11 Cr. Formerly known as Hind Life Science Private Limited and Hind Life Sciences Private Limited. It is led by directors Kesireddy Subhas Chander Reddy and Sambi Reddy Jonnala.
Last AGM: 28 September 2024. Financial statements filed for year ended 31 March 2024. Office: Sy No.290 & 291 Veliminedu, Chityal, Telangana, India – 508114.
As per the financials filed for FY 2025, the company reported a revenue of ₹857.52 Cr, a decline of 9% compared to the previous year.
The company has a workforce of approximately 273 employees as per the latest available data.
The company is associated with 1 brand - Hindys Lab. As per MCA filings, the company has open charges of ₹215.07 Cr and satisfied charges of ₹37.9 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hindyslab.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressSy No.290 & 291 Veliminedu, Chityal, Telangana, India – 508114
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Hindys Lab Private Limited
Hindys Lab Private Limited has undergone 3 name changes throughout its history. The company was previously known as Hind Life Science Private Limited, Hind Life Sciences Private Limited, and Hychem Laborataries Private Limited. The current legal name is Hindys Lab Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Hindys Lab Private Limited | Current |
| Hind Life Science Private Limited | Previous |
| Hind Life Sciences Private Limited | Previous |
| Hychem Laborataries Private Limited | Previous |
CIN History of Hindys Lab Private Limited
Hindys Lab Private Limited has one previous CIN (Corporate Identification Number): U24100AP2007PTC055636. The current CIN is U24100TG2007PTC055636, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2007PTC055636 | Current |
| U24100AP2007PTC055636 | Previous |
Associated Brands with Hindys Lab Private Limited
Hindys Lab Private Limited operates one associated brand: Hindys Lab. These brands represent Hindys Lab Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports pharmaceutical intermediates for global markets. | hindyslab.com |
Competitors & Alternatives of Hindys Lab Private Limited
Brands and companies operating in the same space as Hindys Lab Private Limited include Inventys, Viyash, Blue Jet Healthcare and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Inventys
|
Actives, advanced intermediates, and specialty chemicals are custom manufactured. | Mumbai, India, India | 2005 |
Viyash
|
APIs and intermediates are manufactured by Viyash as a CDMO. | Hyderabad, India, India | 2019 |
Blue Jet Healthcare
|
CDMO focused on manufacturing, supplier, and development of intermediates & APIs | Mumbai, India, India | 1969 |
Ami organics
|
Advanced API intermediates are manufactured for pharmaceutical use. | Surat, India, India | 2007 |
Aparna Pharmaceuticals
|
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | Hyderabad, India, India | 2008 |
HuiSheng Biotech Pharmaceutical
|
APIs, intermediates, and finished dosage forms are manufactured. | Hangzhou, China, China | 2004 |
DUDE CHEM
|
CDMO focused on manufacturing of APIs and intermediates | Berlin, Germany, Germany | 2019 |
Enanti Labs
|
Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. | Hyderabad, India, India | 2007 |
Business Activity of Hindys Lab Private Limited
Hindys Lab Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Hindys Lab Private Limited
Hindys Lab Private Limited is currently managed by 2 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kesireddy Subhas Chander Reddy | Director | 02 Apr 2018 | 8 Years 3 Months | Current |
|
Sambi Reddy Jonnala
Also directs:
Selmar Lab Private Limited, Valary Lab Private Limited, Hetero Drugs Limited and 2 more
|
Director | 20 Dec 2014 | 11 Years 6 Months | Current |
Financials of Hindys Lab Private Limited FY 2024 filings available
Hindys Lab Private Limited reported revenue of ₹857.52 Cr (down 9% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Hindys Lab Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2024 | Others | ₹30 Cr | Open |
| 29 Dec 2022 | Others | ₹45 Cr | Open |
| 01 Sep 2022 | Others | ₹7 Lakh | Open |
| 06 Sep 2021 | Axis Bank Limited | ₹55 Cr | Open |
| 29 Sep 2017 | Others | ₹85 Cr | Open |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Hindys Lab Private Limited
View historical data on people associated with Hindys Lab Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Hindys Lab Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Hindys Lab Private Limited
GSTIN & GST Filing Data of Hindys Lab Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Hindys Lab Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Hindys Lab Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Hindys Lab Private Limited
MSME Payment Delays by Hindys Lab Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Hindys Lab Private Limited
Subsidiaries & Group Companies of Hindys Lab Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Hindys Lab Private Limited with ownership details.
MCA Filings & Documents of Hindys Lab Private Limited
MCA Filings & Documents of Hindys Lab Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Hindys Lab Private Limited
Frequently Asked Questions about Hindys Lab Private Limited
Hindys Lab Private Limited is an active private limited company in the pharma sector based in Chityal, Telangana, India. It was incorporated on 21 September 2007 (19+ years old) and is registered under CIN U24100TG2007PTC055636. The company has 273 employees.
Hindys Lab Private Limited reported revenue of ₹857.52 Cr for FY 2025 (down 9.00% YoY).
The current directors of Hindys Lab Private Limited are:
The primary industry of Hindys Lab Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Hindys Lab Private Limited can be reached at the registered office: Sy No.290 & 291 Veliminedu, Chityal, Telangana, India – 508114, or through the website hindyslab.com.
The authorised capital is ₹11 Cr, and the paid-up capital is ₹11 Cr.